Hjem › Interstitielle lungesygdomme › Texas
Interstitielle lungesygdomme kliniske forsøg i Texas
18 studier for Interstitielle lungesygdomme søger deltagere på steder i Texas.
Byer i Texas
Officiel studietekst (engelsk)
FIBRONEER-ACT: A Study to Test Whether Nerandomilast Helps People With Fibrosing Interstitial Lung Disease at Risk for Disease Progression
- Baylor University Medical Center, Dallas
- Metroplex Pulmonary & Sleep Center, McKinney
- UT Health San Antonio, San Antonio
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 1. okt. 2026 · NCT07540988A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis
- Baylor College of Medicine, Houston
RekruttererFase 3
Alder 40 og opefter · Alle køn · Opdateret 30. sep. 2026 · NCT07201922LAM-001 for the Treatment of Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- Stryde Research, Carrollton
- Baylor University Medical Center, Dallas
- Discovery Clinical Trials, San Antonio
- og 1 flere
RekruttererFase 2
Alder 18 til 80 · Alle køn · Opdateret 29. sep. 2026 · NCT05798923A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease
- GSK Investigational Site, Houston
- GSK Investigational Site, Temple
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 8. sep. 2026 · NCT06572384A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
- GSK Investigational Site, Denison
- GSK Investigational Site, El Paso
RekruttererFase 2/3
Alder 18 og opefter · Alle køn · Opdateret 8. sep. 2026 · NCT05878717A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis
- El Paso Pulmonary Association, El Paso
- Baylor College of Medicine, Houston
- Baylor Scott and White Health, Temple
RekruttererFase 2
Alder 40 og opefter · Alle køn · Opdateret 4. sep. 2026 · NCT06968845Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
- Baylor University Medical Center, Dallas
- Baylor College of Medicine, Houston
- Houston Methodist Hospital, Houston
Rekrutterer
Alder 18 og opefter · Alle køn · Opdateret 2. sep. 2026 · NCT06911632A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD
- Clinical Research Site, Houston
RekruttererFase 2
Alder 18 til 85 · Alle køn · Opdateret 2. sep. 2026 · NCT07333183DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- Baylor University Medical Center, Dallas
- UT Southwest Medical Center Heart and Lung Clinic, Dallas
- Houston Methodist, Houston
- og 1 flere
RekruttererObservationsstudie
Alder 18 og opefter · Alle køn · Opdateret 26. aug. 2026 · NCT06388421PRospective phenotypIng and Multi-omic Endotyping of Progressive Pulmonary Fibrosis
- University of Texas Southwestern, Dallas
RekruttererObservationsstudie
Alder 18 til 80 · Alle køn · Opdateret 18. aug. 2026 · NCT06855329Platform Clinical Study for Conquering Scleroderma
- University of Texas Houston - Division of Rheumatology and Clinical Immunogenetics, Houston
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 18. aug. 2026 · NCT06195072Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
- University of Texas Southwestern, Dallas
- Baylor University Medical Center at Dallas, Dallas
- Baylor College of Medicine, Houston
- og 2 flere
RekruttererObservationsstudie
Alder 21 og opefter · Alle køn · Opdateret 12. aug. 2026 · NCT01915511A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)
- Houston Methodist Hospital, Houston
RekruttererFase 2
Alder 18 til 80 · Alle køn · Opdateret 10. aug. 2026 · NCT07175038Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
- Baylor University Medical Center, Dallas
- UT Southwestern Medical Center-Advanced Lung Clinic, Dallas
- Houston Methodist Outpatient Center, Houston
- og 4 flere
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 13. jul. 2026 · NCT05943535TRANSPIRE: Lung Injury in a Longitudinal Cohort of Pediatric HSCT Patients
- Baylor College of Medicine/Texas Children'S Hospital, Houston
RekruttererObservationsstudie
Op til 24 år · Alle køn · Opdateret 22. jun. 2026 · NCT04098445A Study of Nemolizumab for the Treatment of Adults With Systemic Sclerosis
- Galderma Investigational Site#7096, Arlington
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 31. mar. 2026 · NCT07047690Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis
- University of Texas Southwestern Medical Center, Dallas
- Metroplex Pulmonary and Sleep Center, McKinney
- Research Centers of America, McKinney
RekruttererFase 2
Alder 40 og opefter · Alle køn · Opdateret 12. nov. 2025 · NCT05975983Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)
- aTyr Investigative Site, Dallas
- aTyr Investigative Site, Houston
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 7. maj 2025 · NCT05892614Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.